Maharashtra FDA ex-chief accuses DCGI of delaying action against J & J

In a telephonic interview to ET, Zagade also questioned the basis on which the drug controller ’s office re-issued the import licence for the articular surface replacement (ASR) hip implants even though the company had voluntarily recalled the product in 2010.

Source: The Economic Times - August 28, 2018 Category: Consumer Health News Source Type: news